RxDoctor Payments Data

Mark Connolly, MD

Surgical Oncology · Chicago, ILNPI 1033162839

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,242 of the $1,732 with a category attached, or 71.7%. Intuitive Surgical accounts for 62.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $1,010 and has fallen 78.4% since, to $218 in 2025. That places this record below the midpoint for surgical oncology clinicians in IL, where the typical reported total is $2,301.

$1,732in general payments, 2019–2025

Across 28 payments — averaging $61.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Davol Inc.$168
  • Pfizer$146
  • Puma Biotechnology, Inc.$76
  • Boston Scientific$66
  • Johnson & Johnson$64
  • plus $128 from 7 others

What the payments were for

  • Travel & lodging$37021%
  • Food & beverage$1,24272%
  • Education$1207%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,732 in reported general payments places this provider in the 45th percentile of 55 surgical oncology providers in Illinois.

See all surgical oncology providers in Illinois

Medicare billing

Part B allowed, 2024
$46,749
Medicare patients
91
Services billed
206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →